{{Rsnum
|rsid=4555132
|Chromosome=15
|position=97396008
|Orientation=plus
|GMAF=0.1979
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=RP11-461F11.1
|Gene_s=RP11-461F11.1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 35.4 | 58.4
| HCB | 1.5 | 16.1 | 82.5
| JPT | 2.7 | 18.6 | 78.8
| YRI | 2.7 | 27.9 | 69.4
| ASW | 0.0 | 22.8 | 77.2
| CHB | 1.5 | 16.1 | 82.5
| CHD | 2.8 | 20.2 | 77.1
| GIH | 3.0 | 30.7 | 66.3
| LWK | 6.4 | 27.3 | 66.4
| MEX | 1.7 | 25.9 | 72.4
| MKK | 1.9 | 32.3 | 65.8
| TSI | 6.9 | 32.4 | 60.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs4555132
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363830
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4555132
|overall_frequency_n=20
|overall_frequency_d=128
|overall_frequency=0.15625
|n_genomes=15
|n_genomes_annotated=0
|n_haplomes=18
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}